Categories
Change Password!
Reset Password!
Study confirms modified bismuth quadruple therapy...
New German guidelines provide comprehensive framew...
The German Society for Neurogastroenterology and Motility (Deutsche Gesellschaft für Neurogastroenterologie und Motilität [DGNM]) has r...
Evaluation of folic acid for H. pylori-associated...
This systematic review and meta-analysis determined folic acid's efficiency and safety in treating chronic atrophic gastritis linked with Hel...
Linaclotide vs. lactulose: Which works better for...
In a randomized controlled trial, linaclotide markedly outperformed lactulose in improving both upper and lower gastrointestinal (GI) symptoms in...
Synbiotic-enriched formula softens stools and impr...
According to the findings of a trial led by Xiaoyang Sheng et al., an organic infant formula enriched with synbiotics—specifically Bifidoba...
Study compares tegoprazan vs. PPIs for erosive eso...
A systematic review and meta-analysis has revealed that tegoprazan, a novel potassium-competitive acid blocker (P-CAB), is as effective and safe...
Impact of L. reuteri on infantile colic and parent...
Infantile colic, marked by persistent and excessive crying in otherwise healthy infants, poses a notable concern for both caregivers and medical...
Meta-analysis compares tegoprazan vs. PPI-containi...
In a study issued in "JGH Open", tegoprazan-based therapy offered a more effective first-line treatment option for Helicobacter pylori...
Acotiamide shows encouraging results for pediatric...
A new study suggests that acotiamide, a prokinetic agent commonly used in adults, may also be beneficial in easing the symptoms of functional dys...
Tegoprazan-based triple therapy for H. pylori trea...
This phase III trial investigated tegoprazan's efficacy and safety as part of the first-line triple therapy regimen for Helicobacter pylori (...
